Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States
Samir Kapadia, MD, is the Chairman of the Department of Cardiovascular Medicine at Cleveland Clinic. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Kapadia is board-certified in internal medicine, cardiology, and interventional cardiology.
Specialty/Clinical interests: Percutaneous treatment for valve disease, transcatheter aortic valve replacement (TAVR), Mitraclip, transcatheter mitral valve interventions, complex coronary interventions, atrial septal defect (ASD), paravalvular leak closure and patent foramen ovale (PFO) closure.
Dr. Kapadia has performed more than 1500 TAVR procedures and thousands of other cardiovascular procedures throughout his career. He has published more than 900 peer reviewed papers.
No relationships to disclose
MITRAL VALVE REPAIR: UNDERSTANDING THE LATEST DATA AND MORE
Saturday, March 9, 2024
10:22 AM – 11:52 AM ET
Saturday, March 9, 2024
10:38 AM – 11:52 AM ET
Saturday, March 9, 2024
1:50 PM – 3:33 PM ET
Saturday, March 9, 2024
5:09 PM – 5:17 PM ET
VALVE COMPLICATIONS AND MANAGEMENT | SESSION ONE
Saturday, March 9, 2024
2:00 PM – 3:30 PM ET
VALVE COMPLICATIONS AND MANAGEMENT | SESSION TWO
Saturday, March 9, 2024
3:30 PM – 5:00 PM ET
Live Case from Rigshospitalet | Copenhagen, Denmark
Monday, March 11, 2024
8:00 AM – 8:55 AM ET
Live Case from MedStar Washington Hospital Center | Washington, DC
Monday, March 11, 2024
8:55 AM – 10:00 AM ET
Late-Breaking Clinical Trials | Structural / LAA [Non-CME]
Monday, March 11, 2024
11:40 AM – 12:40 PM ET
CEREBRAL EMBOLIC PROTECTION DEVICES
Monday, March 11, 2024
1:30 PM – 2:33 PM ET
Review of Available EPD Systems in Clinical Trials
Monday, March 11, 2024
1:54 PM – 2:02 PM ET
Moderated Discussion: Embolic Protection for All TAVR Patients - The Pros and Cons
Monday, March 11, 2024
2:10 PM – 2:33 PM ET